CARBOGEN AMCIS - GREENFIELD INJECTABLES FACILITY
CARBOGEN AMCIS, pharmaceutical company dedicated to clinical development including API and drug product manufacturing, is building a new 9,500 square meters facility dedicated to injectables. These new premises will enable CARBOGEN AMCIS to enlarge their services portfolio notably with complex formulation using various chemical and biological agents.
Pharmaplan designed an evolutive facility and conducted a containment risk assessment aiming to define the right strategy to handle high potent products. We developed a flexible design for process, to deal with clinical and commercial batches: development, formulation, and filling of freeze-dried and liquid products. The building will also include research & development and quality control laboratories, as well as administrative functions.
|PROJECT||RIOM2 – Greenfield |
|DURATION||2017 – ongoing|
|TIC||45 m. EUR|